Source: PR Newswire

Press Release: Co-Diagnostics : Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Read full article »
Co-Diagnostics's Competitors | Co-Diagnostics's News | Co-Diagnostics's Financials
Stay up-to-date with the latest news on Co-Diagnostics
Annual Revenue
$100K-5.0M
Employees
100-250
Dwight H. Egan's photo - President & CEO of Co-Diagnostics

President & CEO

Dwight H. Egan

CEO Approval Rating

91/100

Read more
Stay up-to-date with the latest news on Co-Diagnostics